Objective and quantitative equilibriometric evaluation of individual locomotor behaviour in schizophrenia: Translational and clinical implications

J Eval Clin Pract. 2018 Aug;24(4):815-825. doi: 10.1111/jep.12917. Epub 2018 Apr 17.

Abstract

Psychiatry is the only medical specialty that lacks clinically applicable biomarkers for objective evaluation of the existing pathology at a single-patient level. On the basis of an original translational equilibriometric method for evaluation of movement patterns, we have introduced in the everyday clinical practice of psychiatry an easy-to-perform computerized objective quantification of the individual locomotor behaviour during execution of the Unterberger stepping test. For the last 20 years, we have gradually collected a large database of more than 1000 schizophrenic patients, their relatives, and matched psychiatric, neurological, and healthy controls via cross-sectional and longitudinal investigations. Comparative analyses revealed transdiagnostic locomotor similarities among schizophrenic patients, high-risk schizotaxic individuals, and neurological patients with multiple sclerosis and cerebellar ataxia, thus suggesting common underlying brain mechanisms. In parallel, intradiagnostic dissimilarities were revealed, which allow to separate out subclinical locomotor subgroups within the diagnostic categories. Prototypical qualitative (dysmetric and ataxic) locomotor abnormalities in schizophrenic patients were differentiated from 2 atypical quantitative ones, manifested as either hypolocomotion or hyperlocomotion. Theoretical analyses suggested that these 3 subtypes of locomotor abnormalities could be conceived as objectively measurable biomarkers of 3 schizophrenic subgroups with dissimilar brain mechanisms, which require different treatment strategies. Analogies with the prominent role of locomotor measures in some well-known animal models of mental disorders advocate for a promising objective translational research in the so far over-subjective field of psychiatry. Distinctions among prototypical, atypical, and diagnostic biomarkers, as well as between neuromotor and psychomotor locomotor abnormalities, are discussed. Conclusions are drawn about the translational and clinical implications of the new approach and its future perspectives.

Keywords: evaluation; explanation; medical research; patient-centred care; person-centred medicine; philosophy of medicine.

MeSH terms

  • Adult
  • Brain / physiopathology
  • Female
  • Gait Disorders, Neurologic* / diagnosis
  • Gait Disorders, Neurologic* / etiology
  • Gait Disorders, Neurologic* / psychology
  • Gait Disorders, Neurologic* / therapy
  • Humans
  • Locomotion*
  • Longitudinal Studies
  • Male
  • Motor Activity*
  • Patient-Centered Care / methods
  • Psychomotor Disorders* / diagnosis
  • Psychomotor Disorders* / etiology
  • Psychomotor Performance
  • Schizophrenia* / complications
  • Schizophrenia* / diagnosis
  • Schizophrenia* / physiopathology
  • Schizophrenia* / therapy
  • Symptom Assessment / methods
  • Translational Research, Biomedical